HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hoon-Chul Kang Selected Research

Lennox Gastaut Syndrome

12/2021Efficacy and prognosis of long-term, high-dose steroid therapy for Lennox-Gastaut syndrome.
11/2018Rufinamide efficacy and safety in children aged 1-4 years with Lennox-Gastaut syndrome.
2/2015Long-term prognosis of patients with Lennox--Gastaut syndrome in recent decades.
10/2014Adjunctive levetiracetam treatment in pediatric Lennox-Gastaut syndrome.
2/2014Polyunsaturated fatty acid-enriched diet therapy for a child with epilepsy.
5/2012Rufinamide as an adjuvant treatment in children with Lennox-Gastaut syndrome.
9/2011Uncovered primary seizure foci in Lennox-Gastaut syndrome after corpus callosotomy.
8/2009Factors influencing the evolution of West syndrome to Lennox-Gastaut syndrome.
4/2008Clinical efficacy of zonisamide in Lennox-Gastaut syndrome: Korean multicentric experience.
3/2008Comparison of corpus callosotomy and vagus nerve stimulation in children with Lennox-Gastaut syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hoon-Chul Kang Research Topics

Disease

35Epilepsy (Aura)
01/2022 - 08/2006
18Seizures (Absence Seizure)
10/2020 - 08/2006
13Drug Resistant Epilepsy
10/2020 - 01/2007
10Lennox Gastaut Syndrome
12/2021 - 03/2008
7Brain Diseases (Brain Disorder)
12/2021 - 08/2009
6Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked)
01/2019 - 09/2011
5Partial Epilepsies (Epilepsy, Partial)
01/2021 - 06/2015
5Infantile Spasms (West Syndrome)
10/2019 - 08/2009
4Malformations of Cortical Development
01/2021 - 12/2015
2Myoclonic Epilepsies (Myoclonic Encephalopathy)
08/2021 - 04/2018
2Leukoencephalopathies
03/2021 - 01/2021
2Epileptic Syndromes
10/2020 - 07/2012
2Tuberous Sclerosis (Bourneville's Disease)
01/2020 - 06/2017
2Spasm (Spasms)
01/2019 - 01/2018
2Neoplasms (Cancer)
01/2019 - 10/2017
2Mitochondrial Diseases (Mitochondrial Disease)
12/2017 - 09/2013
2Neurodegenerative Diseases (Neurodegenerative Disease)
10/2016 - 01/2012
2Rolandic Epilepsy (Centrotemporal Epilepsy)
08/2014 - 09/2007
2Ketosis
09/2012 - 01/2007
1Headache (Headaches)
01/2022
1Nausea
01/2022
1Hoarseness
08/2021
1Acquired Immunodeficiency Syndrome (AIDS)
01/2021
1Hyperplasia
01/2021
1Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
01/2021
1Demyelinating Diseases (Demyelinating Disease)
05/2019
1Lymphangioma (Cavernous Lymphangioma)
01/2019
1Neurologic Manifestations (Neurological Manifestations)
12/2017
1Liver Failure
12/2017
1Diffuse Cerebral Sclerosis of Schilder (Alpers' Disease)
12/2017
1Mowat-Wilson syndrome
12/2017
1MELAS Syndrome (Syndrome, MELAS)
11/2016
1Inflammation (Inflammations)
10/2016
1Neuroinflammatory Diseases
10/2016
1Gait Ataxia
09/2015

Drug/Important Bio-Agent (IBA)

12Anticonvulsants (Antiepileptic Drugs)IBA
08/2021 - 08/2006
10Pharmaceutical PreparationsIBA
01/2021 - 09/2007
4Prednisolone (Predate)FDA LinkGeneric
10/2019 - 08/2009
4Adrenocorticotropic Hormone (ACTH)FDA Link
01/2019 - 08/2006
3Mitochondrial DNA (mtDNA)IBA
12/2017 - 09/2013
3Levetiracetam (Keppra)FDA LinkGeneric
06/2015 - 02/2010
2SteroidsIBA
12/2021 - 01/2019
2Sodium Channel BlockersIBA
02/2021 - 10/2020
2trans-sodium crocetinate (crocetin)IBA
01/2020 - 06/2017
2VigabatrinFDA Link
10/2019 - 01/2018
2rufinamideFDA Link
11/2018 - 05/2012
2Fatty Acids (Saturated Fatty Acids)IBA
10/2016 - 09/2011
2Carbamazepine (Tegretol)FDA LinkGeneric
06/2015 - 09/2007
2VitaminsIBA
11/2014 - 09/2013
2Zonisamide (Zonegran)FDA LinkGeneric
09/2011 - 04/2008
1ProteomeIBA
03/2021
1Eukaryotic Initiation Factor-2B (Eukaryotic Initiation Factor 2B)IBA
01/2021
1Acetates (Acetic Acid Esters)FDA Link
01/2021
1Butyrates (Butyrate)IBA
01/2021
1Peptide Initiation Factors (Initiation Factor)IBA
01/2021
1UDP-galactose translocatorIBA
01/2021
1NucleotidesIBA
01/2020
1Hormones (Hormone)IBA
10/2019
1Eukaryotic Initiation Factor-4EIBA
10/2019
1Metformin (Glucophage)FDA LinkGeneric
10/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Clobazam (HR 376)IBA
01/2019
1EverolimusFDA Link
01/2019
1Adenosine (Adenocard)FDA LinkGeneric
01/2019
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2019
1Glucose (Dextrose)FDA LinkGeneric
12/2018
1Polysaccharides (Glycans)IBA
12/2018
1mitomycin C-dextranIBA
12/2018
1VemurafenibIBA
11/2018
1Neurotransmitter Receptors (Neurotransmitter Receptor)IBA
11/2018
1RE1-silencing transcription factorIBA
11/2018
1Ion Channels (Ion Channel)IBA
11/2018
1RNA (Ribonucleic Acid)IBA
11/2018
1SodiumIBA
04/2018
1Quinidine (Chinidin)FDA LinkGeneric
01/2018
1Zinc Finger E-box Binding Homeobox 2IBA
12/2017
1Nonsense Codon (Nonsense Mutation)IBA
12/2017
1Member 1 Subfamily D ATP Binding Cassette TransporterIBA
12/2017
1SynaptophysinIBA
10/2017
1Oligodendrocyte Transcription Factor 2IBA
10/2017
1NestinIBA
10/2017
1CannabidiolIBA
06/2017
125-hydroxycholesterolIBA
10/2016
1InflammasomesIBA
10/2016
1TOR Serine-Threonine KinasesIBA
12/2015
1Phosphotransferases (Kinase)IBA
12/2015

Therapy/Procedure

24Ketogenic Diet
01/2022 - 08/2006
20Therapeutics
12/2021 - 08/2006
6High-Protein Low-Carbohydrate Diet (Atkins Diet)
01/2016 - 01/2007
6Diet Therapy (Therapy, Diet)
01/2016 - 12/2006
4Vagus Nerve Stimulation
08/2021 - 06/2007
3Cell- and Tissue-Based Therapy (Cell Therapy)
05/2019 - 01/2012
2Exercise Therapy (Therapy, Exercise)
01/2016 - 08/2014
2Parenteral Nutrition
11/2014 - 09/2012
2Aftercare (After-Treatment)
09/2011 - 09/2008
2Operative Surgical Procedures
09/2011 - 08/2006
1Electrodes (Electrode)
01/2022
1Craniotomy
01/2022
1Activities of Daily Living (ADL)
08/2021
1Liver Transplantation
12/2017